Medtronic is trading 4.2% up today at $88.07 amid a broader market rotation out of megacap tech and into defensive sectors like healthcare.
- The stock's advance appears driven by institutional buying and macro positioning ahead of the upcoming Fed meeting rather than any company-specific developments.
- There have been no fresh earnings reports, FDA decisions, or major deals announced for the company this morning.
- The move aligns with a strong upward trend across the healthcare sector as investors seek stability in defensive equities.